FDA Drug Recalls

Recalls / Class II

Class IID-1609-2012

Product

PYRIDOXINE 100MG/ML INJECTABLE 150 ML 180 ML 300 ML 360 ML 450 ML (5 DIFFERENT PRODUCTS)

Affected lot / code info
Rx #'s: 0370793 0400021 0388933 0400021 0397238 0397238

Why it was recalled

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Recalling firm

Firm
Franck's Lab Inc., d.b.a. Franck's Compounding Lab
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1210 SW 33rd Avenue, Ocala, Florida 34474-5138

Distribution

Quantity
10 units
Distribution pattern
Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies

Timeline

Recall initiated
2012-05-21
FDA classified
2012-08-10
Posted by FDA
2012-08-22
Terminated
2014-08-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1609-2012. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls